# The Efface of Ketamine vs. Lidocaine in the Management of Pain After Laparoscopic Cholecystectomy

> **NCT07248384** · PHASE1 · COMPLETED · sponsor: **Liaquat National Hospital & Medical College** · enrollment: 76 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** IV ketamine 0.5 mg/kg
- **DRUG:** IV Lidocain 60 mg/kg

## Key facts

- **NCT ID:** NCT07248384
- **Lead sponsor:** Liaquat National Hospital & Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-15
- **Primary completion:** 2025-08-20
- **Final completion:** 2025-10-30
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07248384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07248384, "The Efface of Ketamine vs. Lidocaine in the Management of Pain After Laparoscopic Cholecystectomy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07248384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*